aucubin has been researched along with Acute Kidney Injury in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Batičić, L; Broznić, D; Domitrović, R; Marinić, J; Potočnjak, I; Šimić, L | 1 |
1 other study(ies) available for aucubin and Acute Kidney Injury
Article | Year |
---|---|
Aucubin administered by either oral or parenteral route protects against cisplatin-induced acute kidney injury in mice.
Topics: Acute Kidney Injury; Administration, Oral; Animals; Antineoplastic Agents; Cisplatin; Forkhead Box Protein O3; Infusions, Parenteral; Iridoid Glucosides; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; NF-kappa B; Oxidative Stress; Proto-Oncogene Proteins c-akt; STAT3 Transcription Factor | 2020 |